Minimal Residual Disease in Acute Lymphoblastic Leukemia

The panelists, Raoul Tibes, MD, PhD; Stefan Faderl, MD; and Bijal D. Shah, MD, outline methods of measuring minimal residual disease and its role in the management of acute lymphoblastic leukemia.

• Kategorija